Sight Sciences Inc
SGHT8.440USD
0.000
Close 12/23, 16:00（ET）Quotes delayed by 15 min
442.88MMarket Cap
LossP/E TTM
More Details of Sight Sciences Inc Company
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Sight Sciences Inc Info
Ticker SymbolSGHT
Company nameSight Sciences Inc
IPO dateJul 15, 2021
CEOBadawi (Paul)
Number of employees216
Security typeOrdinary Share
Fiscal year-endJul 15
Address4040 Campbell Ave,
CityMENLO PARK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94025
Phone14158890550
Websitehttps://www.sightsciences.com/
Ticker SymbolSGHT
IPO dateJul 15, 2021
CEOBadawi (Paul)
Company Executives of Sight Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.25M
-0.46%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.67M
-0.36%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
83.36K
+38.12%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
75.35K
+69.71%
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
30.95K
-54.78%
Mr. Jeremy Bragg Hayden, J.D.
Mr. Jeremy Bragg Hayden, J.D.
Chief Legal Officer
Chief Legal Officer
24.08K
--
Mr. Brenton Taylor
Mr. Brenton Taylor
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Dr. Tamara R. Fountain, M.D.
Dr. Tamara R. Fountain, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.25M
-0.46%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.67M
-0.36%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
83.36K
+38.12%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
75.35K
+69.71%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Badawi (Paul)
9.93%
Allegro Investment, Inc.
9.62%
KCK, Ltd.
8.27%
Long Focus Capital Management LLC
6.04%
BlackRock Institutional Trust Company, N.A.
4.39%
Other
61.75%
Shareholders
Shareholders
Proportion
Badawi (Paul)
9.93%
Allegro Investment, Inc.
9.62%
KCK, Ltd.
8.27%
Long Focus Capital Management LLC
6.04%
BlackRock Institutional Trust Company, N.A.
4.39%
Other
61.75%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.95%
Individual Investor
20.94%
Hedge Fund
18.20%
Investment Advisor/Hedge Fund
7.28%
Research Firm
0.84%
Pension Fund
0.21%
Bank and Trust
0.09%
Insurance Company
0.03%
Family Office
0.02%
Other
29.43%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
187
26.78M
50.65%
-10.22M
2025Q2
210
37.29M
72.11%
-12.31M
2025Q1
220
37.28M
72.25%
-12.21M
2024Q4
223
37.28M
73.67%
-9.99M
2024Q3
223
36.71M
73.32%
-14.98M
2024Q2
223
36.40M
73.23%
-17.15M
2024Q1
223
36.63M
74.26%
-15.04M
2023Q4
226
36.66M
74.98%
-10.49M
2023Q3
225
39.02M
80.44%
-12.17M
2023Q2
222
40.39M
83.26%
-10.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Badawi (Paul)
5.27M
10.13%
-23.64K
-0.45%
Jul 01, 2025
Allegro Investment, Inc.
5.09M
9.71%
+1.06M
+26.47%
Mar 12, 2025
KCK, Ltd.
4.37M
8.35%
--
--
Jun 30, 2025
Long Focus Capital Management LLC
3.15M
6.02%
+25.00K
+0.80%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
4.44%
+211.36K
+9.99%
Jun 30, 2025
Encrantz (Staffan)
1.99M
3.81%
+177.51K
+9.78%
Jun 06, 2025
The Vanguard Group, Inc.
1.80M
3.45%
+106.97K
+6.30%
Jun 30, 2025
Badawi (David)
1.68M
3.22%
+34.32K
+2.09%
Jul 17, 2025
Americana Partners, LLC
863.92K
1.65%
+863.92K
--
Jun 30, 2025
B Group, Inc.
930.00K
1.78%
+96.40K
+11.56%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0.04%
iShares US Small-Cap Equity Factor ETF
0.02%
Avantis US Small Cap Equity ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Avantis US Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.04%
iShares US Small-Cap Equity Factor ETF
Proportion0.02%
Avantis US Small Cap Equity ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Avantis US Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Sight Sciences Inc?
The top five shareholders of Sight Sciences Inc are:
Badawi (Paul) holds 5.27M shares, accounting for 10.13% of the total shares.
Allegro Investment, Inc. holds 5.09M shares, accounting for 9.71% of the total shares.
KCK, Ltd. holds 4.37M shares, accounting for 8.35% of the total shares.
Long Focus Capital Management LLC holds 3.15M shares, accounting for 6.02% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.33M shares, accounting for 4.44% of the total shares.
Badawi (Paul) holds 5.27M shares, accounting for 10.13% of the total shares.
Allegro Investment, Inc. holds 5.09M shares, accounting for 9.71% of the total shares.
KCK, Ltd. holds 4.37M shares, accounting for 8.35% of the total shares.
Long Focus Capital Management LLC holds 3.15M shares, accounting for 6.02% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.33M shares, accounting for 4.44% of the total shares.
What are the top three shareholder types of Sight Sciences Inc?
The top three shareholder types of Sight Sciences Inc are:
Badawi (Paul)
Allegro Investment, Inc.
KCK, Ltd.
Badawi (Paul)
Allegro Investment, Inc.
KCK, Ltd.
How many institutions hold shares of Sight Sciences Inc (SGHT)?
As of 2025Q3, 187 institutions hold shares of Sight Sciences Inc, with a combined market value of approximately 26.78M, accounting for 50.65% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -21.46%.
What is the biggest source of revenue for Sight Sciences Inc?
In --, the -- business generated the highest revenue for Sight Sciences Inc, amounting to -- and accounting for --% of total revenue.
